Molecular alterations in primary prostate cancer after androgen ablation therapy.

Best CJ, Gillespie JW, Yi Y, Chandramouli GV, Perlmutter MA, Gathright Y, Erickson HS, Georgevich L, Tangrea MA, Duray PH, González S, Velasco A, Linehan WM, Matusik RJ, Price DK, Figg WD, Emmert-Buck MR, Chuaqui RF
Clin Cancer Res. 2005 11 (19 Pt 1): 6823-34

PMID: 16203770 · PMCID: PMC1432092 · DOI:10.1158/1078-0432.CCR-05-0585

MeSH Terms (30)

Aged Androgen Antagonists Androgens Antineoplastic Agents, Hormonal Biopsy Cell Adhesion Chromosome Deletion Chromosome Mapping Chromosomes Cluster Analysis Disease Progression Down-Regulation Gene Deletion Gene Expression Regulation Gene Expression Regulation, Neoplastic Genome Humans Interleukin-6 Lasers Male Middle Aged Models, Statistical Neoplasm Metastasis Oligonucleotide Array Sequence Analysis Oxidative Stress Principal Component Analysis Prostatic Neoplasms RNA Signal Transduction Up-Regulation

Connections (3)

This publication is referenced by other Labnodes entities:

Links